Orbicular Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ORBICULAR, and what generic and branded alternatives to ORBICULAR drugs are available?
ORBICULAR has one approved drug.
Drugs and US Patents for Orbicular
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orbicular | ARSENIC TRIOXIDE | arsenic trioxide | INJECTABLE;INJECTION | 217413-001 | Apr 20, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Orbicular | ARSENIC TRIOXIDE | arsenic trioxide | INJECTABLE;INJECTION | 217413-002 | Apr 20, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.